Fifty-three patients undergoing cataract aspiration by phaco-emulsification under halothane anaesthesia were monitored for cardiac arrhythmias using a cardio-oscilloscope and write-out tracings. In nineteen of these patients adrenaline was injected intraocularly in doses ranging from 0.04 to 0.7 mg. No statistically significant difference was observed between the proportions of cardiac arrhythmias occurring in the group to which adrenaline was given and the group to which it was not. The amounts of adrenaline administered ranged from 0.4 to 68.0 /*g/kg body weight. There was no apparent relationship between the dose (,"g/kg) administered and the occurrence of cardiac arrhythmias. The administration of adrenaline into the anterior eye chamber of patients undergoing cataract aspiration by phaco-emulsification with halothane anaesthesia appears to be safe.
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Phaco-emulsification and aspiration, a technique of cataract removal, is performed using a low frequency (sonic/ultrasonic) needle combined with controlled irrigation and suction. It is important that the pupil is widely dilated for this procedure. Adrenaline in a concentration of 1:1000 has been used intraocularly to achieve maximum pupillary dilatation. Smith and Petruscak (1971) reported five cases in whom adrenaline had been used intraocularly in the presence of halothane for cataract removal by phaco-emulsification. The patients, four children and one adult, ranged from 1 to 25 years of age. Adrenaline in amounts of 0.04-0.5 mg was used. The largest dose, 0.5 mg was given to a 12.2 kg child. The children were monitored with a praecordial stethoscope and the adults with a cardiooscilloscope. Neither arrhythmias nor evidence of systemic effects of adrenaline were noted.
Intraocular injections of 0.2-0.8 mg of adrenaline 1:1000 have been administered to over 300 patients undergoing cataract extraction by phaco-emulsification under halothane anaesthesia at Manhattan Eye and Ear Hospital (Kelman, 1971, personal communication) . Most of the patients were not monitored by cardio-oscilloscope; no arrhythmias or systemic effects of adrenaline were noted.
The purpose of this study was to evaluate the safety of using adrenaline in the anterior chamber of the eye in patients under halothane anaesthesia using more exact cardiac monitoring.
METHOD
Fifty-three consecutive patients having cataract removal by phaco-emulsification and aspiration under halothane anaesthesia were studied. All patients were managed similarly. For children (8), premedication consisted of pentobarbitone 4 mg/kg with atropine 0.02 mg/kg given 45 min before surgery. Adults received hydroxyzine 50 mg, pentobarbitone 100-150 mg, and atropine 0.5-0.8 mg.
In children 12 years of age and under anaesthesia was induced using nitrous oxide and halothane. Lignocaine solution 2% 2 mg/kg was used to provide topical anaesthesia of the larynx and intubation was accomplished without the use of muscle relaxants. Anaesthesia was maintained using nitrous oxide, halothane and assisted ventilation.
In adults, administration of tubocurarine 3 mg i.v. preceded induction of anaesthesia. Thiopentone 4 mg/kg was administered followed by suxamethonium, 1.0 mg/kg. Lignocaine solution 2% 2 mg/kg was used to provide topical anaesthesia of the larynx. Halothane 1-2% and nitrous oxide were used to maintain anaesthesia, respiration being spontaneous.
All patients were continuously monitored with cardio-oscilloscopes from induction to the termina-tion of anaesthesia, and a lead II electrocardiogram was made continuously from the beginning to the end of surgery.
At the onset of the present study, the majority of patients undergoing cataract extraction were given adrenaline into the anterior eye chamber. As the study progressed the surgeons observed striate keratitis in patients who had been given the drug. Because of the possible association of striate keratitis with adrenaline, the use of the drug was curtailed. Before the diminution in the use of intraocular adrenaline, 19 patients who had received adrenaline were meticulously monitored. Two of these patients received two doses.
The 19 patients who were given adrenaline ranged from 3 months to 63 years of age. Using the American Society of Anesthesiologists (ASA) classification, 14 of this group were classified as ASA PS I; the remaining 5 were ASA PS II (4 hypertensive, 1 hypertensive and diabetic). The doses of adrenaline given by intraocular injection ranged from 0.04 to 0.7 mg. The largest dose was 0.5 mg given to a 3-month-old child weighing 7.3 kg (68.0 MgAg)-Arterial blood-gas studies were performed on 12 of these patients during anaesthesia (table I).
The 34 patients who did not receive adrenaline were 2 months to 76 years old. Twenty-four of these patients were classified as ASA PS I, 9 as ASA PS II (4 hypertensive, 1 hypertensive and diabetic, 1 diabetic, 1 emphysema, 1 bronchitis, and 1 over 65 years of age), and 1 as ASA PS III (arteriosclerotic heart disease). Arterial blood-gas studies were performed on 7 of these patients during anaesthesia; all were in normal limits.
No changes took place during anaesthesia requiring modification of the techniques.
RESULTS
Cardiac arrhythmias were noted in 12 of the 53 patients (22.6%) after the administration of halothane alone. Arrhythmias were observed in 10 of the 38 patients (26.3%) classified as PS I and 2 of the 14 (14.3%) classified as PS II (table II) . Five of the 12 were ventricular arrhythmias.
After the administration of adrenaline to the 19 patients, arrhythmias was seen in 5 of the 19 (table  III) . The cardiac arrhythmias in patients who received adrenaline were present before the adrenaline was injected (table I) .
There was no statistically significant difference between the proportions of patients with arrhythmias among cases in whom adrenaline had been used and those in whom it had not. The observed differences lie well within the realm of chance (Standard test of Proportions with Yates Correction). There was no apparent relationship between dose (/^g/kg) and the appearance of arrhythmias in these patients. There was no apparent association between Physical Status classification and the appearance of arrhythmias (table II) .
No significant changes in heart rate or blood pressure were noted in any of the 53 patients.
DISCUSSION
Infiltration with adrenaline during halothane anaesthesia has been considered potentially hazardous. There have been numerous reports of cardiac arrhythmias during simultaneous administration of halothane and adrenaline in both man and animals (Raventos, 1956; Brindle, Gilbert and Millar, 1957; Mushin and Rosen, 1962) . Two cases of cardiac arrest associated with adrenaline infiltration were reported by Rosen and Roe (1963) . One patient received 30 ml of 1:200,000 (0.15 mg) and the other 50 ml of 1:100,000 (0.5 mg) during operations for cystocoele. Both patients were successfully resuscitated. Cases of cardiac arrest also were reported by deLange (1963) and Varejes (1963) . In the former case, the dosage was 80 ml of 1:200,000 (0.4 mg) and in the latter 4 ml of 1:80,000 (0.32 mg). Adrenaline (1:80,000) has been used during halothane anaesthesia to reduce the bleeding in hare-lip and cleft-palate surgery (Jones, 1962; Wallbank, 1970) . Adrenaline was injected around the arteries to produce vasoconstriction. Wallbank studied 45 infants and children. Except for sinus tachycardia and one case of nodal rhythm which spontaneously reverted to sinus rhythm, the author did not find any significant changes. He suggested that doses of 3.5 y"g/kg in infants and 2.5 ^ag/kg in children up to two years of age may be used safely for infiltration injection in the presence of small amounts of halothane.
Topical application of high concentrations of adrenaline (0.5-2%) to the eye for the treatment of open angle glaucoma has been associated with systemic effects (Kolker and Hetherington, 1970) . Ballin, Becker and Goldman (1966) studied patients undergoing tonography. The incidence of premature ventricular contractions was found to be high in a group of patients receiving topical adrenaline.
Guidelines for the safe use of adrenaline during halothane anaesthesia were offered by Katz, Matteo and Papper (1962) . They suggested that subcutaneous adrenaline in concentrations of 1:100,000 -1:200,000 and a total adult dose not greater than 10 ml of 1:100,000 over 10 min or more than 30 ml/hour are safe with halothane provided adequate ventilation is assured. They stress the importance of site of injection in reference to the systemic absorption and the amount injected in unit time. The guidelines for subcutaneous injection may not be applicable to the intraocular injection.
In our study, the overall incidence of arrhythmias is similar to that reported by Johnstone and Nisbett (1961) , Dodd, Sims and Bone (1962) and Reinikainen and Pontinen (1966) as occurring during the administration of halothane anaesthesia without adrenaline. The largest dose administered here was 0.5 mg to a 7.3 kg infant (68.0 ^g/kg). This would correspond to a dose of 5.0 mg for a 70 kg man, far above the recommended 0.1 mg for subcutaneous use. In this patient, no arrhythmias were noted and there was no evidence of any systemic effects of adrenaline. It is possible that some of the drug was lost in the suction accompanying the irrigation. However, in this particular case, there was an interval of 5 min between the intraocular injection and the insertion of the phaco-emulsification probe. It should be stressed that all patients received topical application of lignocaine to the larynx since the antiarrhythmic properties of this drug are well known. The globe does not appear to be a good site for absorption into the systemic circulation.
The iris is richly supplied with adrenergic receptors (Graymore, 1970) and may be able to capture the adrenaline injected into the anterior chamber of the eye rapidly.
